Tbx5-dependent pathway regulating diastolic function in congenital heart disease

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 14, 2008, Pages 5519-5524

  Zhu, Yonghong ^a,b   Gramolini, Anthony O ^b,c   Walsh, Mark A ^a   Zhou, Yu Qing ^a   Slorach, Cameron ^a   Friedberg, Mark K ^a   Takeuchi, Jun K ^a,e   Sun, Hui ^b   Henkelman, R Mark ^a,c   Backx, Peter H ^b,c,d   Redington, Andrew N ^a   MacLennan, David H ^b   Bruneau, Benoit G ^a,b,c,e  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Calcium; Cardiac; SERCA2a; Transcription; Ventricular

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CALCIUM; TRANSCRIPTION FACTOR TBX5;

ANIMAL CELL; ARTICLE; ATP2A2 GENE; CALCIUM TRANSPORT; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; DIASTOLE; DIASTOLIC DYSFUNCTION; ENDOPLASMIC RETICULUM; GENE; GENE ACTIVATION; GENE EXPRESSION; HAPLOIDY; HEART MUSCLE RELAXATION; HEART VENTRICLE; HOLT ORAM SYNDROME; HUMAN; MOUSE; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; SARCOPLASMIC RETICULUM; TBX5 GENE;

ANIMALS; CALCIUM; CASE-CONTROL STUDIES; DIASTOLE; GENE EXPRESSION REGULATION; HEART DEFECTS, CONGENITAL; HUMANS; MICE; PROMOTER REGIONS (GENETICS); SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; SIGNAL TRANSDUCTION; T-BOX DOMAIN PROTEINS;

EID: 44449162472     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0801779105     Document Type: Article

References (37)

1. Kass DA, Bronzwaer JG, Paulus WJ (2004) What mechanisms underlie diastolic dysfunction in heart failure? Circ Res 94:1533-1542.
2. MacLennan DH, Kranias EG (2003) Phospholamban: A crucial regulator of cardiac contractility. Nat Rev Mol Cell Biol 4:566-577.
3. Maclennan DH (2004) Interactions of the calcium ATPase with phospholamban and sarcolipin: Structure, physiology and pathophysiology. J Muscle Res Cell Motil 25:600-601.
4. Dillmann WH (1996) Regulation of expression of cardiac sarcoplasmic reticulum proteins under pathophysiological conditions. Mol Cell Biochem 157:125-128.
5. Srivastava D (2006) Making or breaking the heart: From lineage determination to morphogenesis. Cell 126:1037-1048.
6. Bruneau BG (2008) The developmental genetics of congenital heart disease. Nature 451:943-948.
7. Bruneau BG, et al. (2001) A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease. Cell 106:709-721.
8. Naya FJ, et al. (2002) Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factor. Nat Med 8:1303-1309.
9. Pashmforoush M, et al. (2004) Nkx2-5 pathways and congenital heart disease: Loss of ventricular myocyte lineage specification leads to progressive cardiomyopathy and complete heart block. Cell 117:373-386.
10. Costantini D, et al. (2005) The homeodomain transcription factor Irx5 establishes the mouse cardiac ventricular repolarization gradient. Cell 123:347-358.
11. Ismat FA, et al. (2005) Homeobox protein Hop functions in the adult cardiac conduction system. Circ Res 96:898-903.
12. Mori AD, Bruneau BG TBX5 mutations and congenital heart disease: Holt-Oram syndrome revealed. Curr Opin Cardiol 19:211-215.
13. Mori AD, et al. (2006) Tbx5-dependent rheostatic control of cardiac gene expression and morphogenesis. Dev Biol 297:566-586.
14. Zhou YQ, et al. (2005) Abnormal cardiac inflow patterns during postnatal development in a mouse model of Holt-Oram syndrome. Am J Physiol 289:H992-H1001.
15. McFadden DG, et al. (2004) The Hand1 and Hand2 transcription factors regulate expansion of the embryonic cardiac ventricles in a gene dosage-dependent manner. Development 132:189-201.
16. 2+ signaling in cardiac myocyte excitation-transcription coupling. J Clin Invest 116:675-682.
17. Backs J, Song K, Bezprozvannaya S, Chang S, Olson EN (2006) CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy. J Clin Invest 116:1853-1864.
18. Song K, et al. (2006) The transcriptional coactivator CAMTA2 stimulates cardiac growth by opposing class II histone deacetylases. Cell 125:453-466.
19. Gomez-Ospina N, Tsuruta F, Barreto-Chang O, Hu L, Dolmetsch R (2006) The C terminus of the L-type voltage-gated calcium channel Ca(V)1.2 encodes a transcription factor. Cell 127:591-606.
20. Eidem BW, et al. (2004) Impact of cardiac growth on Doppler tissue imaging velocities: A study in healthy children. J Am Soc Echocardiogr 17:212-221.
21. Takizawa T, et al. (2003) Transcription factor Sp1 regulates SERCA2 gene expression in pressure-overloaded hearts: A study using in vivo direct gene transfer into living myocardium. J Mol Cell Cardiol 35:777-783.
22. Thuerauf DJ, et al. (2001) Sarco/endoplasmic reticulum calcium ATPase-2 expression is regulated by ATF6 during the endoplasmic reticulum stress response: Intracellular signaling of calcium stress in a cardiac myocyte model system. J Biol Chem 276:48309-48317.
23. Oka T, et al. (2006) Cardiac-specific deletion of Gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability. Circ Res 98:837-845.
24. Bisping E, et al. (2006) Gata4 is required for maintenance of postnatal cardiac function and protection from pressure overload-induced heart failure. Proc Natl Acad Sci USA 103:14471-14476.
25. Nagueh SF, et al. (1997) Doppler tissue imaging: A noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 30:1527-1533.
26. Zile MR, Brutsaert DL (2002) New concepts in diastolic dysfunction and diastolic heart failure. Part II: Causal mechanisms and treatment. Circulation 105:1503-1508.
27. Warnes CA (2005) The adult with congenital heart disease: Born to be bad? J Am Coll Cardiol 46:1-8.
28. Webb G, Gatzoulis MA (2006) Atrial septal defects in the adult: Recent progress and overview. Circulation 114:1645-1653.
29. Norozi K, et al. (2006) Incidence and risk distribution of heart failure in adolescents and adults with congenital heart disease after cardiac surgery. Am J Cardiol 97:1238-1243.
30. Meyer-Wittkopf M, Cooper S, Vaughan J, Sholler G (2001) Three-dimensional (3D) echocardiographic analysis of congenital heart disease in the fetus: Comparison with cross-sectional (2D) fetal echocardiography. Ultrasound Obstet Gynecol 17:485-492.
31. Pawelec-Wojtalik M, Wojtalik M, Mrowczynski W, Surmacz R, Quereshi SA (2006) Comparison of cardiac function in children after surgical and Amplatzer occluder closure of secundum atrial septal defects. Eur J Cardiothorac Surg 29:89-92.
32. De Backer JF, et al. (2006) Primary impairment of left ventricular function in Marfan syndrome. Int J Cardiol 112:353-358.
33. Luo W, et al. (1994) Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation. Circ Res 75:401-409.
34. Gramolini AO, et al. (2006) Cardiac-specific overexpression of sarcolipin in phospholamban null mice impairs myocyte function that is restored by phosphorylation. Proc Natl Acad Sci USA 103:2446-2451.
35. 2+ ATPase (SERCA2a) activity and impairs cardiac function in mice. Proc Natl Acad Sci USA 101:9199-9204.
36. Gramolini AO, et al. (2004) Sarcolipin retention in the endoplasmic reticulum depends on its C-terminal RSYQY sequence and its interaction with sarco(endo)plasmic Ca(2+)-ATPases. Proc Natl Acad Sci USA 101:16807-16812.
37. McDermott DA, et al. (2005) TBX5 genetic testing validates strict clinical criteria for Holt-Oram syndrome. Pediatr Res 58:981-986.